The Panorama test by Natera is a prenatal screening test that uses a blood sample from the mother to assess the risk of the fetus developing common chromosomal conditions that affect the baby’s health. Panorama uses SNP-based (single nucleotide polymorphism) technology to provide highly accurate results and unique insights for singleton and twin pregnancies.
Panorama™ can be performed starting at nine weeks of gestation.
Children with the most common form of SMA have access to genetic therapy to improve their quality and lifespan. Treatment can begin shortly after birth.
1 in 10 African Americans are carriers of sickle cell disease.
In the general population, sickle cell disease is more common than Down syndrome. Early diagnosis allows for referral to a specialized clinic.
Source: www.hematology.org
Source: rarediseases.org
Consider this test in the following cases:
The methodology used for this test is as follows:
Blood: No fasting required.
Up to 10 calendar days.
Medical request.
| Type | Description |
| Technique | Next-Generation Sequencing (NGS) |
| Accuracy | 99% |
Main Office Rua Bento Gonçalves, 59, Room 802 — Centro, Marau, RS — 99150-000
Porto Alegre Office Rua Gomes Jardim, 301 , Room 918/909 — Santana, Porto Alegre, RS — 90620-130